A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients
Clinical trial NCT02026583 · COMPLETED
Trial details
- NCT number
- NCT02026583
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2017-04-28
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.